According to the latest market report published by Credence Research, Inc. ?ENT Devices Market - Growth, Future Prospects and Competitive Analysis, 2015 - 2025? the global ENT devices market was valued at US$ 10.97 Bn in 2016, and is expected to reach US$ 18.87 Bn by 2025, expanding at a CAGR of  6.1% from 2017 to 2025.

Browse the full report ENT Devices Market - Growth, Future Prospects and Competitive Analysis, 2017 ? 2025 at http://www.credenceresearch.com/report/ent-devices-market

Market Insights

ENT device market will grow significantly during forecast period due to growing number of geriatric population, favorable reimbursement scenario for ENT procedures in developed countries and increasing adoption of minimally invasive ENT procedures. For the purpose of the study ENT devices market is segmented on the basis of product type such as diagnostic devices, surgical ENT devices, hearing aid devices, hearing implants, nasal splints and voice prosthesis devices. It is studied that, currently hearing aid devices is major revenue contributor due to increase in prevalence of hearing disability, hearing loss and technological advances in hearing aids devices. Diagnostic devices will show lucrative market growth during forecast period due to rising number of target population, developing new technology, rising treatment awareness and growing healthcare infrastructure.

In the base year 2016, North America dominated ENT devices market in terms of revenue and growth was primarily driven by United States. Factors such as higher number of geriatric population, higher healthcare awareness, upsurge in funding by government agencies and private organizations in healthcare system, continues technological advancement for the development of novel ENT devices are driving the market growth in North America. On the other hand Asia Pacific will show fastest market growth during forecast period due to rising incidence of ENT problems, growing partnership of key players with local manufacturer and growing healthcare infrastructure.

Market Competition Assessment:

The ENT Devices market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Acclarent, Inc., Atos Medical AB, Cochlear Limited, GN ReSound A/S, Hoya Corporation, KARLSTORZ GmbH & Co., Medtronic plc., Olympus Corporation, Rion Co. Ltd., Smith & Nephew plc., Sonova Holdings AG, Stryker Corporation, Widex A/S, William Demant Holdings A/S and others.

Key Market Movements:

• Factors such as increasing number of geriatric population, rising number of problem associate with ENT, rising healthcare expenditure, increase in presence of prominent players in the ENT devices market is driving the market growth of ENT devices market globally.
• Rising adoption of minimally invasive surgeries over traditional surgical procedure would drive the ENT devices market during the forecast period.
• However, higher cost of devices and inadequate reimbursement policies in some developing countries are negatively impacting the growth of ENT devices market.

Browse the full report ENT Devices Market - Growth, Future Prospects and Competitive Analysis, 2017 ? 2025 at http://www.credenceresearch.com/report/ent-devices-market

Latest Reports:

Hydrofluoroolefins Market: http://www.credenceresearch.com/report/hydrofluoroolefins-market

Blog: https://globenewswire.com/news-release/2018/03/15/1437950/0/en/Lyocell-Fiber-Market-is-Expected-to-Grow-at-the-CAGR-of-8-9-During-2017-2025-Credence-Research.html

ENT (NASDAQ: XENT) is a publicly traded health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Intersect ENT is best known for developing the first bioabsorbable drug-eluting sinus stent PROPEL, which delivers anti-inflammatory medication directly to the sinuses. The company holds over 20 issued patents in the United States and more than 80 patents and patent applications worldwide. The company was named on the Forbes list of America's Most Promising Companies and was also on the Firece 15 list of Most Promising Companies in 2013. Source : Wikipedia

ENT Devices in India?

Otolaryngology, Otorhinolaryngology or Ear Nose & Throat (ENT) is the field of medicine involving those specific areas of the human body and other related areas of the neck and face. In India, otolaryngology medical devices allow treatment of issues such as chronic ear infection, sinusitis, snoring and sleep apnea, hearing loss, allergies and hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness, and head and neck cancer.

Major ENT devices subcategories utilized in India are:

Inspection device such as otoscopes, ENT microscopes, pharyngoscopes, laryngoscopes, nasal endoscopes and bronchoscopes

Equipment such as ENT workstations, ENT chairs, exam tables, surgical tables and hearing test chambers

Therapeutic devices such as hearing aids, cochlear implants, auditory brainstem implants,

middle ear prostheses, apnea devices, sinus balloon catheters and vocal fold augmentation devicesConsumables such as ear packing, nasal packing and tracheostomy tubes The global ENT device market is forecasted to exceed $13 billion by 2017 growing at 7 percent annually and is driven by the increased adoption of technologically advanced equipment. In India, there are ENT specialists in every significant city but advanced surgeries are offered only in the largest urban areas.

[Ref: amritt.com]

About:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Blog:http://www.mobilecomputingtoday.co.uk/6818/ent-devices-market-expected-reach-18-87-terms-value-2025-credence-research/

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com